Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Clinical trial NCT04423718 · COMPLETED

Trial details

NCT number: NCT04423718
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration

Start date: 2020-08-11
Primary completion: 2022-07-27
Enrollment: 1011

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.